On May 9, 2024, Gilead Sciences, Inc announced that it held its annual general meeting of shareholders on May 8, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, requesting that the Board adopt a policy requiring the Company?s named executive officers to retain at least 25% of net-after tax shares of stock acquired through equity pay programs until reaching normal retirement age (at least age 60) was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.06 USD | +3.62% |
|
+0.56% | -19.69% |
Jun. 14 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
Jun. 14 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.69% | 81.06B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Declaration of Voting Results by Gilead Sciences